{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Promethazine&page=6", "query": { "intervention": "Promethazine", "page": 6 }, "page_size": 10 }, "pagination": { "page": 6, "page_size": 10, "total_count": 488, "total_pages": 49, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Promethazine&page=7&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Promethazine&page=5&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-20T09:21:58.216Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00926289", "title": "Telmisartan 80mg Plus Hydrochlorothiazide 25mg First Line in Moderate or Severe Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "Telmisartan", "type": "DRUG" }, { "name": "Hydrochlorothiazide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 894, "start_date": "2009-06", "completion_date": null, "has_results": true, "last_update_posted_date": "2014-06-27", "last_synced_at": "2026-10-20T09:21:58.216Z", "location_count": 18, "location_summary": "Athens, Alabama • Mobile, Alabama • Lomita, California + 14 more", "locations": [ { "city": "Athens", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Lomita", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Fort Lauderdale", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00926289" }, { "nct_id": "NCT02142712", "title": "Histamine Glutamate Antagonism in Stroke", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acute Cerebrovascular Accident", "Cerebral Edema" ], "interventions": [ { "name": "Diphenhydramine", "type": "DRUG" }, { "name": "Pantoprazole", "type": "DRUG" }, { "name": "Famotidine", "type": "DRUG" }, { "name": "Dextromethorphan", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 3, "start_date": "2014-12", "completion_date": "2014-12", "has_results": true, "last_update_posted_date": "2015-12-15", "last_synced_at": "2026-10-20T09:21:58.216Z", "location_count": 1, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02142712" }, { "nct_id": "NCT05627557", "title": "A Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Participants With Childhood Onset Idiopathic Nephrotic Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Childhood Idiopathic Nephrotic Syndrome" ], "interventions": [ { "name": "Obinutuzumab", "type": "DRUG" }, { "name": "MMF", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Methylprednisolone", "type": "DRUG" }, { "name": "Acetaminophen/ Paracetamol", "type": "DRUG" }, { "name": "Diphenhydramine Hydrochloride", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "25 Years", "sex": "ALL", "summary": "2 Years to 25 Years" }, "enrollment_count": 85, "start_date": "2023-03-29", "completion_date": "2026-08-27", "has_results": true, "last_update_posted_date": "2026-10-14", "last_synced_at": "2026-10-20T09:21:58.216Z", "location_count": 8, "location_summary": "Palo Alto, California • Miami, Florida • Orlando, Florida + 5 more", "locations": [ { "city": "Palo Alto", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05627557" }, { "nct_id": "NCT03493945", "title": "Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Metastatic Castration-resistant Prostate Cancer", "Prostate Cancer", "Prostate Neoplasm", "Advanced Solid Tumor", "Solid Tumor", "Non-metastatic Castration-resistant Prostate Cancer" ], "interventions": [ { "name": "M7824", "type": "BIOLOGICAL" }, { "name": "N-803", "type": "DRUG" }, { "name": "MVA-BN-Brachyury", "type": "BIOLOGICAL" }, { "name": "FPV-Brachyury", "type": "BIOLOGICAL" }, { "name": "Epacadostat", "type": "DRUG" }, { "name": "Acetaminophen", "type": "DRUG" }, { "name": "Ibuprofen", "type": "DRUG" }, { "name": "Naproxen", "type": "DRUG" }, { "name": "Benadryl", "type": "OTHER" }, { "name": "EKG", "type": "DIAGNOSTIC_TEST" }, { "name": "Bone scan", "type": "DIAGNOSTIC_TEST" }, { "name": "CT chest, abdomen and pelvis", "type": "DIAGNOSTIC_TEST" }, { "name": "MRI", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "BIOLOGICAL", "DRUG", "OTHER", "DIAGNOSTIC_TEST" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "120 Years", "sex": "ALL", "summary": "18 Years to 120 Years" }, "enrollment_count": 59, "start_date": "2018-05-01", "completion_date": "2024-10-08", "has_results": true, "last_update_posted_date": "2025-09-30", "last_synced_at": "2026-10-20T09:21:58.216Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03493945" }, { "nct_id": "NCT03185130", "title": "Intravenous Fluids in Benign Headaches Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Headache" ], "interventions": [ { "name": "Normal Saline 5mL", "type": "DRUG" }, { "name": "Normal Saline 20mL/kg", "type": "DRUG" }, { "name": "Prochlorperazine 0.15 mg/kg up to 10 mg IV", "type": "DRUG" }, { "name": "Diphenhydramine 1 mg/kg up to 50 mg IV", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University Medical Center of Southern Nevada", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "10 Years to 65 Years" }, "enrollment_count": 58, "start_date": "2017-05-16", "completion_date": "2019-05-15", "has_results": true, "last_update_posted_date": "2024-06-06", "last_synced_at": "2026-10-20T09:21:58.216Z", "location_count": 1, "location_summary": "Las Vegas, Nevada", "locations": [ { "city": "Las Vegas", "state": "Nevada" } ], "official_url": "https://clinicaltrials.gov/study/NCT03185130" }, { "nct_id": "NCT01199978", "title": "Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Vestibular Schwannoma", "Acoustic Neuroma" ], "interventions": [ { "name": "Fractionated proton radiation", "type": "RADIATION" }, { "name": "Losartan", "type": "DRUG" } ], "intervention_types": [ "RADIATION", "DRUG" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2011-03-08", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2026-09-11", "last_synced_at": "2026-10-20T09:21:58.216Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01199978" }, { "nct_id": "NCT05157464", "title": "Losartan Use to Mitigate Arthrofibrosis Following Total Join Arthroplasty", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Arthrofibrosis" ], "interventions": [ { "name": "Losartan", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "NYU Langone Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2023-09-01", "completion_date": "2024-12-31", "has_results": false, "last_update_posted_date": "2023-12-01", "last_synced_at": "2026-10-20T09:21:58.216Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05157464" }, { "nct_id": "NCT01332318", "title": "Simulated Driving Study in Restless Legs Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Restless Legs Syndrome" ], "interventions": [ { "name": "XP13512", "type": "DRUG" }, { "name": "Diphenhydramine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "XenoPort, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "21 Years to 65 Years" }, "enrollment_count": 130, "start_date": "2007-04", "completion_date": "2007-11", "has_results": true, "last_update_posted_date": "2013-07-26", "last_synced_at": "2026-10-20T09:21:58.216Z", "location_count": 1, "location_summary": "Albuquerque, New Mexico", "locations": [ { "city": "Albuquerque", "state": "New Mexico" } ], "official_url": "https://clinicaltrials.gov/study/NCT01332318" }, { "nct_id": "NCT00638443", "title": "Lumbar Stenosis Outcomes Research (LUSTOR)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Lumbar Spinal Stenosis" ], "interventions": [ { "name": "Pregabalin", "type": "DRUG" }, { "name": "Diphenhydramine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Rochester", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 29, "start_date": "2008-03", "completion_date": "2010-09", "has_results": true, "last_update_posted_date": "2016-06-20", "last_synced_at": "2026-10-20T09:21:58.216Z", "location_count": 1, "location_summary": "Rochester, New York", "locations": [ { "city": "Rochester", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00638443" }, { "nct_id": "NCT01613118", "title": "Randomized, Double-Blind, Safety and Efficacy Study of RE-021 (Sparsentan) in Focal Segmental Glomerulosclerosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Focal Segmental Glomerulosclerosis" ], "interventions": [ { "name": "RE-021 (Sparsentan)", "type": "DRUG" }, { "name": "Irbesartan", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Travere Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "8 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "8 Years to 75 Years" }, "enrollment_count": 109, "start_date": "2014-03", "completion_date": "2024-03-25", "has_results": true, "last_update_posted_date": "2025-05-15", "last_synced_at": "2026-10-20T09:21:58.216Z", "location_count": 28, "location_summary": "San Diego, California • Torrance, California • Denver, Colorado + 19 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Miami", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01613118" } ] }